Ascendis Pharma A/S Deferred Tax Expense Income
Ascendis Pharma A/S (ASND) reported Deferred Tax Expense Income of -EUR 3.09 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-03.
Discontinued › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2019-04-03
| Period end | Deferred Tax Expense Income 12 month |
|---|---|
| 2018-12-31 | -3.09M EUR 20-F · filed 2019-04-03 |
| 2017-12-31 | -86.00K EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | -144.00K EUR 20-F · filed 2019-04-03 |